Understanding urinary tract dilation in fetuses and newborns
Urinary Tract Dilations in Prenatal and Postnatal Life
This study is trying to see how doctors in Slovakia handle urinary tract dilation in unborn babies and newborns to improve care and outcomes for these patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | Female |
| Sponsor | SonoClinic Research network |
| Locations | 1 site (Záborské) |
| Trial ID | NCT06317623 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the awareness and management of urinary tract dilation among medical professionals in Slovakia. It involves a questionnaire survey to evaluate current practices and predict the severity of postnatal outcomes for fetuses diagnosed with urinary tract dilation during pregnancy. The study seeks to establish a standardized model for prenatal and postnatal care to improve outcomes for affected patients. By identifying high-risk cases, the study aims to enhance multidisciplinary cooperation in managing urinary tract dilation.
Who should consider this trial
Good fit: Ideal candidates include singleton pregnant women whose fetuses were diagnosed with isolated urinary tract dilation before 28 weeks of pregnancy and newborns with prenatally diagnosed urinary tract dilation requiring follow-up.
Not a fit: Patients with multiple pregnancies, urinary tract dilation diagnosed in the third trimester, or associated anomalies may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved prenatal and postnatal care for infants with urinary tract dilation, potentially preventing serious complications.
How similar studies have performed: While there may be limited data on similar studies in Slovakia, the approach of standardizing care for urinary tract dilation is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * Singleton pregnant women whose fetuses were diagnosed with dilation of the urinary tract as an isolated US finding before the 28th week of pregnancy. Fetal patients with subsequent US control in the third trimester after the 28th week of pregnancy. * Newborns and children with prenatally diagnosed UTD, which, depending on the severity, required a postnatal examination by a pediatric nephrologist within a month after birth and then in his follow-up up to 6 months after birth. Exclusion criteria: * Multiple pregnancies * Urinary tract dilation in fetuses diagnosed in the third trimester * Associated anomalies in fetuses * Aneuploidy * Newborns and children monitored by someone other than a selected pediatric nephrologist Patients who were lost from follow-up
Where this trial is running
Záborské
- Svetlana Jánošová — Záborské, Slovakia (Recruiting)
Study contacts
- Study coordinator: Svetlana Jánošová
- Email: svetlana.janosova@gmail.com
- Phone: +421908369470
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.